Abstract
New linear and cyclic guanidines were synthesized and tested in vitro for their antifungal activity toward clinically relevant strains of Candida species, in comparison to fluconazole. Macrocyclic compounds showed a minimum inhibitory concentration in the micromolar range and a biological activity profile in some cases better than that of fluconazole. One macrocyclic derivative was also tested against Aspergillus species and showed high antifungal activity comparable to that of amphotericin B and itraconazole.
Original language | English |
---|---|
Pages (from-to) | 7376-7379 |
Journal | Journal of Medicinal Chemistry |
Volume | 52 |
Issue number | 23 |
DOIs | |
Publication status | Published - 2009 |